問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kuang Tien General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-06-09 - 2029-11-26
Condition/Disease
Pulmonary Disease, Chronic Obstructive
Test Drug
預充填式注射劑
Participate Sites8Sites
Recruiting8Sites
2025-03-01 - 2030-06-30
The time elapsed before the first occurrence of any of the following events: • Hospitalization due to HF • Non-hospitalized HF • Death due to CV
Baxdrostat Dapagliflozin
Participate Sites18Sites
Recruiting18Sites
2023-12-01 - 2027-12-31
Participate Sites9Sites
Recruiting9Sites
2023-12-28 - 2028-12-31
Participate Sites6Sites
Recruiting6Sites
2026-06-01 - 2031-06-30
Participate Sites14Sites
Recruiting14Sites
2024-12-01 - 2030-12-31
2024-01-22 - 2028-12-31
Participate Sites12Sites
Recruiting12Sites
2025-06-01 - 2028-12-31
Participate Sites10Sites
Recruiting10Sites
2025-07-01 - 2030-12-31
Participate Sites23Sites
Recruiting23Sites
2025-03-01 - 2028-12-31
全部
